• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

具有“非典型”囊性纤维化特征患者的表型和基因特征分析

Phenotypic and genetic characterization of patients with features of "nonclassic" forms of cystic fibrosis.

作者信息

Groman Joshua D, Karczeski Barbara, Sheridan Molly, Robinson Terry E, Fallin M Daniele, Cutting Garry R

机构信息

Cyctic Fibrosis Foundation Genotyping Center and McKusick-Nathans Institute of Genetic Medicine, Bloomberg School of Public Health, Johns Hopkins University School of Medicine, 733 N. Broadway, Baltimore, MD 21287, USA.

出版信息

J Pediatr. 2005 May;146(5):675-80. doi: 10.1016/j.jpeds.2004.12.020.

DOI:10.1016/j.jpeds.2004.12.020
PMID:15870673
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3380804/
Abstract

OBJECTIVE

To determine which features of incomplete or "nonclassic" forms of cystic fibrosis (CF) are associated with deleterious CF transmembrane conductance regulator gene ( CFTR ) mutations, and to explore other etiologies for features not associated with deleterious CFTR mutations.

STUDY DESIGN

Clinical features were compared between 57 patients with deleterious mutations in each CFTR and 63 with no deleterious mutations. The Shwachman Bodian Diamond syndrome gene ( SBDS ) was sequenced to search for mutations in patients with no deleterious CFTR mutations and steatorrhea to determine if any had unrecognized Shwachman-Diamond syndrome (SDS).

RESULTS

The presence of a common CF-causing mutation, absence of the vas deferens, and Pseudomona aeruginosa in the sputum correlated with the presence of two deleterious CFTR mutations, whereas sweat chloride concentration, diagnostic criteria for CF, and steatorrhea did not. However, sweat chloride concentration correlated with CFTR mutation status in patients infected with P aeruginosa. One patient had disease-causing mutations in each SBDS .

CONCLUSIONS

Presence of a common CF-causing mutation, absence of the vas deferens and/or P aeruginosa infection in a patient with features of nonclassic CF are predictive of deleterious mutations in each CFTR , whereas steatorrhea in the same context is likely to have etiologies other than CF transmembrane conductance regulator (CFTR) dysfunction.

摘要

目的

确定不完全或“非典型”囊性纤维化(CF)形式的哪些特征与有害的CF跨膜传导调节因子基因(CFTR)突变相关,并探索与有害CFTR突变无关的特征的其他病因。

研究设计

比较了57例每个CFTR中存在有害突变的患者与63例无有害突变的患者的临床特征。对施瓦赫曼-博迪安-戴蒙德综合征基因(SBDS)进行测序,以寻找无有害CFTR突变且有脂肪泻的患者中的突变,以确定是否有未被识别的施瓦赫曼-戴蒙德综合征(SDS)。

结果

常见的CF致病突变的存在、输精管缺如和痰液中的铜绿假单胞菌与两个有害CFTR突变的存在相关,而汗液氯化物浓度、CF的诊断标准和脂肪泻则无关。然而,在感染铜绿假单胞菌的患者中,汗液氯化物浓度与CFTR突变状态相关。一名患者每个SBDS中都有致病突变。

结论

具有非典型CF特征的患者中存在常见的CF致病突变、输精管缺如和/或铜绿假单胞菌感染可预测每个CFTR中的有害突变,而在相同情况下的脂肪泻可能有除CF跨膜传导调节因子(CFTR)功能障碍以外的病因。

相似文献

1
Phenotypic and genetic characterization of patients with features of "nonclassic" forms of cystic fibrosis.具有“非典型”囊性纤维化特征患者的表型和基因特征分析
J Pediatr. 2005 May;146(5):675-80. doi: 10.1016/j.jpeds.2004.12.020.
2
Variant cystic fibrosis phenotypes in the absence of CFTR mutations.无CFTR基因突变时的囊性纤维化变异表型。
N Engl J Med. 2002 Aug 8;347(6):401-7. doi: 10.1056/NEJMoa011899.
3
CFTR genotype and clinical outcomes of adult patients carried as cystic fibrosis disease.囊性纤维化病携带成年患者的 CFTR 基因型与临床结局
Gene. 2014 May 1;540(2):183-90. doi: 10.1016/j.gene.2014.02.040. Epub 2014 Feb 26.
4
Heterogeneous spectrum of mutations in CFTR gene from Indian patients with congenital absence of the vas deferens and their association with cystic fibrosis genetic modifiers.来自印度先天性输精管缺如患者的CFTR基因突变异质性谱及其与囊性纤维化遗传修饰因子的关联。
Mol Hum Reprod. 2014 Sep;20(9):827-35. doi: 10.1093/molehr/gau047. Epub 2014 Jun 23.
5
A cystic fibrosis transmembrane conductance regulator splice variant with partial penetrance associated with variable cystic fibrosis presentations.一种具有部分外显率且与囊性纤维化不同表现相关的囊性纤维化跨膜传导调节因子剪接变体。
Am J Respir Crit Care Med. 1997 Jun;155(6):1914-20. doi: 10.1164/ajrccm.155.6.9196095.
6
Phenotypic characterisation of patients with intermediate sweat chloride values: towards validation of the European diagnostic algorithm for cystic fibrosis.汗液氯化物值处于中间范围的患者的表型特征:迈向欧洲囊性纤维化诊断算法的验证
Thorax. 2009 Aug;64(8):683-91. doi: 10.1136/thx.2008.104752. Epub 2009 Mar 23.
7
Applying Cystic Fibrosis Transmembrane Conductance Regulator Genetics and CFTR2 Data to Facilitate Diagnoses.应用囊性纤维化跨膜传导调节因子遗传学和CFTR2数据辅助诊断。
J Pediatr. 2017 Feb;181S:S27-S32.e1. doi: 10.1016/j.jpeds.2016.09.063.
8
A mutation in the cystic fibrosis transmembrane conductance regulator gene associated with elevated sweat chloride concentrations in the absence of cystic fibrosis.囊性纤维化跨膜传导调节因子基因的一种突变,在无囊性纤维化的情况下与汗液氯化物浓度升高相关。
Hum Mol Genet. 1998 Apr;7(4):729-35. doi: 10.1093/hmg/7.4.729.
9
Analysis of the CFTR gene in Iranian cystic fibrosis patients: identification of eight novel mutations.伊朗囊性纤维化患者CFTR基因分析:鉴定出八个新突变
J Cyst Fibros. 2008 Mar;7(2):102-9. doi: 10.1016/j.jcf.2007.06.001. Epub 2007 Jul 27.
10
Distribution of Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Mutations in a Cohort of Patients Residing in Palestine.居住在巴勒斯坦的一组患者中囊性纤维化跨膜传导调节因子(CFTR)突变的分布情况。
PLoS One. 2015 Jul 24;10(7):e0133890. doi: 10.1371/journal.pone.0133890. eCollection 2015.

引用本文的文献

1
Increased prevalence of variants and susceptibility to CRS: A real-world study based on Chinese children.变应性鼻炎(CRS)变异的患病率增加及其易感性:一项基于中国儿童的真实世界研究
Heliyon. 2024 Mar 14;10(7):e27681. doi: 10.1016/j.heliyon.2024.e27681. eCollection 2024 Apr 15.
2
CFTR variant testing: a technical standard of the American College of Medical Genetics and Genomics (ACMG).CFTR 变异检测:美国医学遗传学与基因组学学会(ACMG)的技术标准。
Genet Med. 2020 Aug;22(8):1288-1295. doi: 10.1038/s41436-020-0822-5. Epub 2020 May 14.
3
Nationwide genetic analysis for molecularly unresolved cystic fibrosis patients in a multiethnic society: implications for preconception carrier screening.多民族社会中分子诊断不明的囊性纤维化患者的全国性基因分析:对孕前携带者筛查的意义
Mol Genet Genomic Med. 2017 Feb 19;5(3):223-236. doi: 10.1002/mgg3.278. eCollection 2017 May.
4
Phenotypes of California CF Newborn Screen-Positive Children with CFTR 5T Allele by TG Repeat Length.按三核苷酸重复序列长度划分的携带CFTR 5T等位基因的加利福尼亚州囊性纤维化新生儿筛查呈阳性儿童的表型
Genet Test Mol Biomarkers. 2016 Sep;20(9):496-503. doi: 10.1089/gtmb.2016.0102. Epub 2016 Jul 22.
5
Loss of carbonic anhydrase XII function in individuals with elevated sweat chloride concentration and pulmonary airway disease.汗液氯化物浓度升高和肺部气道疾病患者碳酸酐酶XII功能丧失。
Hum Mol Genet. 2016 May 15;25(10):1923-1933. doi: 10.1093/hmg/ddw065. Epub 2016 Feb 23.
6
Refining the continuum of CFTR-associated disorders in the era of newborn screening.在新生儿筛查时代完善与囊性纤维化跨膜传导调节因子(CFTR)相关疾病的连续谱。
Clin Genet. 2016 May;89(5):539-49. doi: 10.1111/cge.12711. Epub 2016 Jan 20.
7
Molecular testing for cystic fibrosis carrier status practice guidelines: recommendations of the National Society of Genetic Counselors.囊性纤维化携带者状态的分子检测实践指南:美国国家遗传咨询师协会的建议
J Genet Couns. 2014 Feb;23(1):5-15. doi: 10.1007/s10897-013-9636-9. Epub 2013 Sep 7.
8
CFTR transcription defects in pancreatic sufficient cystic fibrosis patients with only one mutation in the coding region of CFTR.胰腺功能正常的囊性纤维化患者仅在 CFTR 编码区有一个突变时存在 CFTR 转录缺陷。
J Med Genet. 2011 Apr;48(4):235-41. doi: 10.1136/jmg.2010.083287. Epub 2010 Nov 20.
9
Effects of gender and age at diagnosis on disease progression in long-term survivors of cystic fibrosis.性别和诊断时年龄对囊性纤维化长期生存者疾病进展的影响。
Am J Respir Crit Care Med. 2010 Sep 1;182(5):614-26. doi: 10.1164/rccm.201001-0092OC. Epub 2010 May 6.
10
Guidelines for diagnosis of cystic fibrosis in newborns through older adults: Cystic Fibrosis Foundation consensus report.从新生儿到老年人的囊性纤维化诊断指南:囊性纤维化基金会共识报告。
J Pediatr. 2008 Aug;153(2):S4-S14. doi: 10.1016/j.jpeds.2008.05.005.

本文引用的文献

1
Nonclassic cystic fibrosis and CFTR-related diseases.非典型囊性纤维化和囊性纤维化跨膜传导调节因子相关疾病。
Curr Opin Pulm Med. 2003 Nov;9(6):498-503. doi: 10.1097/00063198-200311000-00009.
2
Atypical cystic fibrosis--diagnostic and management dilemmas.非典型囊性纤维化——诊断与管理困境
J R Soc Med. 2003;96 Suppl 43(Suppl 43):2-10.
3
Nonclassic cystic fibrosis: a clinical conundrum.非典型囊性纤维化:一个临床难题。
Pediatr Pulmonol. 2003 Jul;36(1):10-2. doi: 10.1002/ppul.10286.
4
Mutations in SBDS are associated with Shwachman-Diamond syndrome.SBDS基因的突变与施瓦赫曼-戴蒙德综合征相关。
Nat Genet. 2003 Jan;33(1):97-101. doi: 10.1038/ng1062. Epub 2002 Dec 23.
5
What is cystic fibrosis?什么是囊性纤维化?
N Engl J Med. 2002 Aug 8;347(6):439-42. doi: 10.1056/NEJMe020070.
6
Variant cystic fibrosis phenotypes in the absence of CFTR mutations.无CFTR基因突变时的囊性纤维化变异表型。
N Engl J Med. 2002 Aug 8;347(6):401-7. doi: 10.1056/NEJMoa011899.
7
Nasal potential difference measurements in patients with atypical cystic fibrosis.非典型囊性纤维化患者的鼻电位差测量
Eur Respir J. 2001 Jun;17(6):1208-15. doi: 10.1183/09031936.01.00092501.
8
Considerations for a multiaxis nomenclature system for medical genetics.医学遗传学多轴命名系统的考量因素。
Genet Med. 2001 Jul-Aug;3(4):290-3. doi: 10.1097/00125817-200107000-00004.
9
Mutation and haplotype analysis of the CFTR gene in atypically mild cystic fibrosis patients from Northern Ireland.北爱尔兰非典型轻度囊性纤维化患者CFTR基因的突变与单倍型分析
J Med Genet. 2001 Feb;38(2):136-9. doi: 10.1136/jmg.38.2.136.
10
Comprehensive mutation screening in a cystic fibrosis center.囊性纤维化中心的全面突变筛查
Pediatrics. 2001 Feb;107(2):280-6. doi: 10.1542/peds.107.2.280.